U.S., Nov. 21 -- ClinicalTrials.gov registry received information related to the study (NCT07238764) titled 'OCT-based DAPT Cessation in HBR Patients' on May 09.
Brief Summary: This study investigates whether patients with diabetes mellitus (DM) and a high risk of bleeding can safely stop dual antiplatelet therapy (DAPT) earlier than usual after receiving a special type of stent called a polymer-free amphilimus-eluting stent. DAPT, which combines aspirin and a P2Y12 inhibitor, is typically prescribed for six months after stent placement to prevent blood clots. However, in patients at high risk of bleeding, stopping DAPT early may be beneficial if the artery has healed properly.
The study uses optical coherence tomography (OCT), a high-res...